Search Results - "WEISS, Thomas S"

Refine Results
  1. 1

    Myristoylated PreS1‐domain of the hepatitis B virus L‐protein mediates specific binding to differentiated hepatocytes by Meier, Anja, Mehrle, Stefan, Weiss, Thomas S., Mier, Walter, Urban, Stephan

    Published in Hepatology (Baltimore, Md.) (01-07-2013)
    “…Chronic infection with the human hepatitis B virus (HBV) is a global health problem and a main cause of progressive liver diseases. HBV exhibits a narrow host…”
    Get full text
    Journal Article
  2. 2

    Hepatocyte polarization is essential for the productive entry of the hepatitis B virus by Schulze, Andreas, Mills, Kerry, Weiss, Thomas S., Urban, Stephan

    Published in Hepatology (Baltimore, Md.) (01-02-2012)
    “…Human hepatitis B virus (HBV) is characterized by a high species specificity and a distinct liver tropism. Within the liver, HBV replication occurs in…”
    Get full text
    Journal Article
  3. 3

    Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways by Weiss, Thomas S, Lupke, Madeleine, Ibrahim, Sara, Buechler, Christa, Lorenz, Julia, Ruemmele, Petra, Hofmann, Ute, Melter, Michael, Dayoub, Rania

    Published in PloS one (06-09-2017)
    “…Nonalcoholic fatty liver disease (NAFLD) covers a spectrum from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Free fatty acids (FFA)…”
    Get full text
    Journal Article
  4. 4

    Does hepatic steatosis affect drug metabolizing enzymes in the liver? by Buechler, Christa, Weiss, Thomas S

    Published in Current drug metabolism (01-01-2011)
    “…Bioavailability and effects of xenobiotics are dependent on absorption, metabolism and elimination of the respective compounds. Hepatocytes are critically…”
    Get more information
    Journal Article
  5. 5

    Hepatic Amyloid Beta-42-Metabolizing Proteins in Liver Steatosis and Metabolic Dysfunction-Associated Steatohepatitis by Gross, Simon, Danielyan, Lusine, Buechler, Christa, Kubitza, Marion, Klein, Kathrin, Schwab, Matthias, Melter, Michael, Weiss, Thomas S

    “…Amyloid beta (Aβ) plays a major role in the pathogenesis of Alzheimer's disease and, more recently, has been shown to protect against liver fibrosis…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Saturated Fat-Mediated Upregulation of IL-32 and CCL20 in Hepatocytes Contributes to Higher Expression of These Fibrosis-Driving Molecules in MASLD by Schilcher, Katharina, Dayoub, Rania, Kubitza, Marion, Riepl, Jakob, Klein, Kathrin, Buechler, Christa, Melter, Michael, Weiss, Thomas S

    “…Metabolic dysfunction-associated steatotic liver disease (MASLD) comprises a spectrum of liver diseases, ranging from liver steatosis to metabolic…”
    Get full text
    Journal Article
  8. 8

    FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells by Schuster, Susanne, Penke, Melanie, Gorski, Theresa, Gebhardt, Rolf, Weiss, Thomas S., Kiess, Wieland, Garten, Antje

    “…Nicotinamide phosphoribosyltransferase (NAMPT) is the key enzyme of the NAD salvage pathway starting from nicotinamide. Cancer cells have an increased demand…”
    Get full text
    Journal Article
  9. 9

    Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma by Krautbauer, Sabrina, Meier, Elisabeth M., Rein-Fischboeck, Lisa, Pohl, Rebekka, Weiss, Thomas S., Sigruener, Alexander, Aslanidis, Charalampos, Liebisch, Gerhard, Buechler, Christa

    Published in Biochimica et biophysica acta (01-11-2016)
    “…Lipid composition affects membrane function, cell proliferation and cell death and is changed in cancer tissues. Hepatocellular carcinoma (HCC) is an…”
    Get full text
    Journal Article
  10. 10

    Interleukin-1ß Attenuates Expression of Augmenter of Liver Regeneration (ALR) by Regulating HNF4α Independent of c-Jun by Nimphy, Jonas, Ibrahim, Sara, Dayoub, Rania, Kubitza, Marion, Melter, Michael, Weiss, Thomas S

    “…Inflammasomes and innate immune cells have been shown to contribute to liver injury, thereby activating Kupffer cells, which release several cytokines,…”
    Get full text
    Journal Article
  11. 11

    Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells by Wobser, Hella, Dorn, Christoph, Weiss, Thomas S, Amann, Thomas, Bollheimer, Cornelius, Büttner, Roland, Schölmerich, Jürgen, Hellerbrand, Claus

    Published in Cell research (01-08-2009)
    “…Despite the initial belief that non-alcoholic fatty liver disease is a benign disorder, it is now recognized that fibrosis progression occurs in a significant…”
    Get full text
    Journal Article
  12. 12

    GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis by Amann, Thomas, Maegdefrau, Ulrike, Hartmann, Arndt, Agaimy, Abbas, Marienhagen, Jörg, Weiss, Thomas S, Stoeltzing, Oliver, Warnecke, Christina, Schölmerich, Jürgen, Oefner, Peter J, Kreutz, Marina, Bosserhoff, Anja K, Hellerbrand, Claus

    Published in The American journal of pathology (01-04-2009)
    “…Accelerated glycolysis is one of the biochemical characteristics of cancer cells. The glucose transporter isoform 1 ( GLUT1 ) gene encodes a key rate-limiting…”
    Get full text
    Journal Article
  13. 13

    Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma by Feder, Susanne, Kandulski, Arne, Schacherer, Doris, Weiss, Thomas S, Buechler, Christa

    “…The chemoattractant adipokine chemerin is related to the metabolic syndrome, which is a risk factor for different cancers. Recent studies provide evidence that…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases by Berger, Alexander, Venturelli, Sascha, Kallnischkies, Mascha, Böcker, Alexander, Busch, Christian, Weiland, Timo, Noor, Seema, Leischner, Christian, Weiss, Thomas S., Lauer, Ulrich M., Bischoff, Stephan C., Bitzer, Michael

    Published in The Journal of nutritional biochemistry (01-06-2013)
    “…Kaempferol is a natural polyphenol belonging to the group of flavonoids. Different biological functions like inhibition of oxidative stress in plants or animal…”
    Get full text
    Journal Article
  19. 19

    Hepatic Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor Levels Decline in Hepatitis C but Are Not Associated with Progression of Hepatocellular Carcinoma by Weber, Florian, Utpatel, Kirsten, Evert, Katja, Weiss, Thomas S, Buechler, Christa

    Published in Biomedicines (19-10-2024)
    “…Bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) is an antagonist of transforming growth factor (TGF)-β type 1 signaling. BAMBI…”
    Get full text
    Journal Article
  20. 20

    Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα) by Thomas, Maria, Burk, Oliver, Klumpp, Britta, Kandel, Benjamin A, Damm, Georg, Weiss, Thomas S, Klein, Kathrin, Schwab, Matthias, Zanger, Ulrich M

    Published in Molecular pharmacology (01-03-2013)
    “…The nuclear receptor peroxisome proliferator-activated receptor (PPAR)α is known primarily as a regulator of fatty acid metabolism, energy balance, and…”
    Get more information
    Journal Article